TPA-enhanced motility and invasion in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1: Selective role of PKC-α and its inhibition by a combination of PDBu-induced PKC downregulation and antisense oligonucleotides treatment

Clinical and Experimental Metastasis

Volumn 17, Issue 4, 1999, Pages 351-360

  Shimao, Yoshiya ^a   Nabeshima, Kazuki ^a   Inoue, Teruhiko ^a   Koono, Masashi ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Metastasis; Migration; PKC ; TPA; Tumor invasion

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL DIBUTYRATE; PROTEIN KINASE C;

ARTICLE; CANCER INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; METASTASIS; PROTEIN EXPRESSION; RECTUM CARCINOMA;

ADENOCARCINOMA; BASE SEQUENCE; CARBAZOLES; DOWN-REGULATION; HUMANS; INDOLES; ISOENZYMES; NAPHTHALENES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGONUCLEOTIDES, ANTISENSE; PHORBOL 12,13-DIBUTYRATE; PHORBOL ESTERS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RECTAL NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0032856186     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Liotta LA. Tumor invasion and metastases role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 1986; 46: 1-7.
2. Taniguchi S, Tatsuka M, Nakamatsu K et al. High invasiveness associated with augmentation of motility in a fos-transferred highly metastatic rat 3Y1 cell line. Cancer Res 1989; 49; 6738-44.
3. Nabeshima K, Komada N, Kishi J et al. TPA-enhanced invasion of Matrigel associated with augmentation of cell motility but not metalloproteinase activity in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1. Int J Cancer 1993; 55: 974-81.
4. Crawford JM. The gastrointestinal tract. In Cotran RS, Kumar V, Robbins SL (eds): Pathologic Basis of Disease, 5th ed. Philadelphia: W.B. Saunders 1994; 755-829.
5. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607-14.
6. Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1993; 291: 329-43.
7. Dekker LV, Parker PJ. Protein kinase C - a question of specificity. Trends Biochem Sci 1994; 19: 73-7.
8. Gopalakrishna R, Barsky SH. Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci USA 1988; 85: 612-16.
9. Blobe GC, Obeid LM, Hannun YA. Regulation of protein kinase C and role in cancer biology. Cancer Metasl Rev 1994; 13: 411-31.
10. Dumont JA, Jones WD, Bitonti AJ. Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C. Cancer Res 1992; 52: 1195-200.
11. Liu B, Maher RJ, Hannun YA et al. 12(S)-HETE enhancement of prostate tumor cell invasion: Selective role of PKCα. J Natl Cancer Inst 1994; 86: 1145-51.
12. Mapelli E, Banfi P, Sala E et al. Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoenzymes. Int J Cancer 1994; 57: 281-86.
13. Schwartz GK, Jiang J, Kelsen D, Albino AP. Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. J Natl Cancer Inst 1993; 85: 402-7.
14. Platet N, Prevostel C, Derocq D et al. Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells. Int J Cancer 1998; 75: 750-6.
15. Dean NM, Mckay R, Miraglia L et al. Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression. Cancer Res 1996; 56: 3499-507.
16. Komada N, Nabeshima K, Koita H et al. Characteristics of a metastatic variant to the liver of human rectal adenocarcinoma cell line RCM-1. Invas Metast 1993; 13: 38-49.
17. Nabeshima K, Asada Y, Inoue T et al. Modulation of E-cadherin expression in TPA-induced cell motility: human well differentiated adenocarcinoma cells move as coherent sheets associated with phosphorylation of E-cadherin-catenin complex. Lab Invest 1997; 76: 139-51.
18. Nabeshima K, Inoue T, Shimao Y et al. TPA-induced cohort migration of well differentiated human rectal adenocarcinoma cells: Cells move in a RGD-dependent manner on fibronectin produced by cells, and phosphorylation of E-cadherin/catenin complex is induced independent of cell-extracellular matrix interactions. Virchows Archiv 1998; 433: 243-53.
19. Marutsuka K, Suzumiya J, Kataoka H et al. Correlation between urokinase-type plasminogen activator production and the metastatic ability of human rectal cancer cells. Invas Metast 1991; 11: 181-91.
20. Fournier A, Hardy SJ, Clark KJ, Murray AW. Phorbol ester induces differential membrane-association of protein kinase C subspecies in human platelets. Biochem Biophys Res Commun 1989; 161: 556-61.
21. Dean NM, Mckay R, Condon TP, Benett CF. Inhibition of protein kinase C-α expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule I (ICAM-1) mRNA by phorbol esters. J Biol Chem 1994; 269; 16416-24.
22. Maier JAM, Ragnotti G. An oligomer targeted against protein kinase C α prevents interleukin-1α induction of cyclooxygenase expression in human endothelial cells. Exp Cell Res 1993; 205: 52-8.
23. Busuttil SJ, Morehouse DL, Youkey JR, Singer HA. Antisense suppression of protein kinase C-α and -δ in vascular smooth muscle. J Surg Res 1996; 63: 137-42.
24. 1, γ, δ, and ε by phorbol esters of different biological activities. FEBS Lett 1991; 288: 5-9.
25. Kobayashi E, Nakano H, Morimoto M, Tamaoki T, Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989; 159: 548-53.
26. Hidaka H, Inagaki M, Kawamoto S, Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 1984; 23: 5036-41.
27. ++ dependent protein kinase. Biochem Biophys Res Commun 1986; 135: 397-402.
28. Martiny-Baron G, Kazanietz MG, Mischank H et al. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem 1993; 268: 9194-7.
29. Ishizuka T, Yamamoto M, Kajita K et al. Insulin stimulates novel protein kinase C in rat adipocytes. Biochem Biophys Res Comm 1992; 183: 814-20.
30. Goode NT, Hajibagheri MAN, Parker PJ. Protein kinase C (PKC)-induced PKC down-regulation. Association with up-regulation of vesiele traffic. J Biol Chem 1995; 270: 2669-73.
31. Niggli V, Zimmermann A, Keller H. Inhibition of protein kinase C-dependent protein phosphorylation correlates with increased polarity and locomotion in Walker 256 carcinosarcoma cells. Int J Cancer 1996; 65: 473-8.
32. Llosas M, Del M, Batlle E et al. Evidence for a role of conventional protein kinase-Cα in the control of homotypic contacts and cell scattering of HT-29 human intestinal cells. Biochem J 1996; 315: 1049-54.
33. Yazaki T, Ahmad S, Chahlavi A et al. Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase Cα phosphorothioate oligodeoxynucleotide. Mol Pharmacol 1996; 50: 236-42.
34. Yokoyama Y, Ito T, Hanson V et al. PMA-induced reduction in invasiveness is associated with hyperphosphorylation of MARCKS and talin in invasive baldder cancer cells. Int J Cancer 1998; 75: 774-9.
35. Gschwendt M, Kittstein W, Marks F. Protein kinase C activation by phorbol esters: do cysteine-rich regions and pseudosubstrate motifs play a role? Trends Biochem Sci 1991; 16: 167-9.
36. Isakov N, Memahon P, Altman A. Selective post-transcriptional down-regulution of protein kinase C isoenzymes in leukemic T cells chronically treated with phorbol ester. J Biol Chem 1990; 265: 2091-7.
37. Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurg 1996; 39: 235-52.
38. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995; 268: 233-9.